Efficacy and Safety of a Low-Dose 21-Day Combined Oral Contraceptive Containing Ethinylestradiol 20μg and Drospirenone 3mg

被引：0
|
作者：
D. Cibula
U. Karck
H. G. Weidenhammer
J. Kunz
S. Alincic
J. Marr
机构：
[1] Charles University,Department of Obstetrics and Gynaecology, General Faculty Hospital
[2] University of Freiburg,Department of Obstetrics and Gynaecology
[3] Klarastr,undefined
[4] Hospital Zollikerberg,undefined
[5] Schering AG,undefined
[6] MDG G&A,undefined
来源：
Clinical Drug Investigation | 2006年 / 26卷
关键词：
Combine Oral Contraceptive; Contraceptive Efficacy; Drospirenone; Withdrawal Bleeding; Normal Menstruation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: The purpose of this study was to assess the efficacy and safety of a new low-dose oral contraceptive containing ethinylestradiol 20μg and drospirenone 3mg (EE 20μg/drsp 3mg).
引用
收藏
页码：143 / 150
页数：7
相关论文
共 50 条
  • [1] Efficacy and safety of a low-dose 21-day combined oral contraceptive containing ethinylestradiol 20μg and drospirenone 3mg
    Cibula, D
    Karck, U
    Weidenhammer, HG
    Kunz, J
    Alincic, S
    Marr, J
    CLINICAL DRUG INVESTIGATION, 2006, 26 (03) : 143 - 150
  • [2] Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone
    Bachmann, G
    Sulak, PJ
    Sampson-Landers, C
    Benda, N
    Marr, J
    CONTRACEPTION, 2004, 70 (03) : 191 - 198
  • [3] Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen
    Laszlo Hernadi
    Marr, Joachim
    Trummer, Dietmar
    De Leo, Vincenzo
    Petraglia, Felice
    CONTRACEPTION, 2009, 80 (01) : 18 - 24
  • [4] Dose finding in a low-dose 21-day combined oral contraceptive containing gestodene
    Lüdicke, F
    Sullivan, H
    Spona, J
    Elstein, M
    CONTRACEPTION, 2001, 64 (04) : 243 - 248
  • [5] Efficacy and safety of a twenty-four-day oral contraceptive regimen with ethinylestradiol (20 μg) and drospirenone (3 mg)
    Bachmann, G
    Sulak, PJ
    Marr, J
    OBSTETRICS AND GYNECOLOGY, 2004, 103 (04): : 92S - 92S
  • [6] Suppression of ovarian activity with a low-dose 21/7-day regimen oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg in Japanese and Caucasian women
    Anzai, Yuzuru
    Heger-Mahn, Doris
    Schellschmidt, Ilka
    Marr, Joachim
    CONTRACEPTION, 2012, 86 (01) : 28 - 34
  • [7] The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 μg and ethinylestradiol 15 μg
    Bocci, A.
    Spielniann, D.
    Azzini, Pr
    Guaschino, Pr
    Affronti, G.
    Villani, Pr
    Boselli, Pr
    Genazzani, Pr
    Flamigni, Z. C.
    Omodei, U.
    Bolis, P.
    Marsoni, V.
    Luerti, M.
    Simenel, J. L.
    Ouvry-Neveu, B.
    Andre, G.
    David, S.
    Durand, J. L.
    Ehret-Mentre, C.
    Gensburger, J. M.
    Goetzmann, P.
    Jung-Faerber, S.
    Keller, D.
    Lempereur, M.
    Plumere, C.
    Spielmann, A.
    Katz, J. L.
    Sebaoun, J.
    Belaisch, J.
    Hammer, F.
    Salama, B.
    Aissaoui, S.
    Taube, A. M.
    Nakache, H.
    Soria, J.
    Joffo, M.
    Lardenois, H.
    Leclerc, P.
    Ponsar, C.
    Saubry-Bobet, V.
    Blaiset, E.
    Veyres, F.
    Clamp, M.
    Menon, K. V. K.
    Moran, D. G.
    Randall, S.
    Shaw, P. J.
    Bruni, V.
    Massobrio, M.
    Crosignani, P.
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 1999, 4 : 9 - 15
  • [8] Influence of combined oral contraceptive pill containing Drospirenone 3mg and Ethinylestradiol 20mcg on circadian arterial stiffness indicators in perimenopausal women
    Mychka, V. B.
    Tolstov, S. N.
    Salov, I. A.
    Kirillova, M. Yu.
    GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2012, 34 (01): : 260 - 261
  • [9] An investigation of ovulation inhibition with a low-dose combined oral contraceptive containing 75 μg gestodene and 20 μg ethinylestradiol
    Archer, DF
    Gast, MJ
    GYNECOLOGICAL ENDOCRINOLOGY, 1998, 12 : 7 - 12
  • [10] Effect of a low-dose oral contraceptive containing 20 μg ethinylestradiol and 150 μg desogestrel on dysmenorrhea
    Callejo, J
    Díaz, J
    Ruiz, A
    García, RM
    CONTRACEPTION, 2003, 68 (03) : 183 - 188
12345